Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients.
| Image |  |
|---|---|
| Description | scientific article published in August 2017 |
| Author/s |
author: Arsela Prelaj Antonio Passaro |
| Publication date | August 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |